Use of recombinant Interferon gamma in pédiatrie patients with advanced juvenile chronic arthritis

Biotherapy

Volumn 11, Issue 1, 1998, Pages 15-20

  Coto, C ^a,b,c   Varela, G ^a,b,c   Hernandez V ^a,b,c   Del Rosario, M ^a,b,c   Lopez Saura P ^a,b,c  

^a Academic Paediatric Hospital Pedro Borrás   (Cuba)

^b Centra de Investigations Biologicas   (Cuba)

^c Centra de Investigaciones Biolgicas   (Cuba)

Author keywords

Biological response modifiers; Interferon gamma; Juvenile chronic arthritis

Indexed keywords

RECOMBINANT GAMMA INTERFERON;

ADOLESCENT; ARTICLE; CHILD; CHRONIC DISEASE; CLINICAL TRIAL; FEMALE; FOLLOW UP; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MALE; TREATMENT OUTCOME; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG USE; PRIORITY JOURNAL; TREATMENT FAILURE; TREATMENT INDICATION;

ADOLESCENT; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERFERON-GAMMA, RECOMBINANT; MALE; TREATMENT OUTCOME;

EID: 0031610762     PISSN: 0921299X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007932130188     Document Type: Article

References (29)

1. Furst D E. Toxicity of antirheumatic medications in children with juvenile arthritis. J Rheumatol 1992;19 (Suppl. 33): 11-15.
2. Brauning J. Interferons and rheumatoid arthritis: insight into interferon biology. Immunol Today 1987;8 (12):372-374.
3. Oben HJ and Hofschneider PH. Interferon for chronic polyarthritis. Positive effect in clinical evaluation. Deutsche Med Wochenschr 1985; 110: 1766-1769.
4. Seitz M, Manz G, Franke M. Use of recombinant human interferon gamma in patients with rheumatoid arthritis. Z Rheumatol 1986; 45: 92-99.
5. Firestein GS, Weisman MH and Zvaifler NJ. Parenteral interferon gamma in rheumatoid arthritis. Effect on disease activity and peripheral blood monocytes (abstr). Arthritis Rheum 1987; 30: S115.
6. Lemmel EM, Brackertz D, Franke M, et al. Results of multicenter placebo controlled double-blind randomized phase 111 clinical study of treatment of rheumatoid arthritis with recombinant interferon gamma. Rheumatol Internat 1988; 8: 87-93.
7. VeysEM.MielantsH, VerbruggenG.etal. Interferon gamma in rheumatoid arthritis. A double-blind study comparing human recombinant interfered! gamma with placebo. J Rheumatol, 1988; 15:570-574.
8. Cannon GW, Pincus SH, Emkey RD, et al. Double-blind trial of recombinant gamma Interferon versus placebo in the treatment of rheumatoid arthritis. Arthritis Rheum 1989; 32: 964-973.
9. Machold KP, Smolen JS. Recombinant human gamma interferon in the treatment of rheumatoid arthritis. Double blind placebo-controlled crossover study (abstr). Arthritis Rheum 1989; 32:5131.
10. Meske S, Weber S, Wirzberger M, and Peter H Therapy of rheumatoid arthritis with recombinant gamma Interferon. Z Rheumatol 1989; 48(2): 101-102.
11. Cannon GW, Emkey RD, Denes A, et al. Prospective twoyear follow-up of recombinant Interferon gamma in rheumatoid arthritis. J Rheumatol 1990; 17: 304-310.
12. Pernice W, Schumann A, Dippel J, Suske J, Vegel P. Therapy for systemic juvenile rheumatoid arthritis with gammainterferon: a pilot study of nine patients. Arthritis Rheum 1989; 32(5): 643-646.
13. Coto C, Varela G, López-Saura P, Hernândez V, Valle J. Use of recombinant gamma interferon in two pediatrie patients with Juvenile Rheumatoid Arthritis (JRA). J Interferon Res 1991; ll(suppll): S243.
14. Coto C, Varela G, Hernândez V, López-Saura P Use of recombinant gamma interferon in six pédiatrie patients with Juvenile Rheumatoid Arthritis (JRA). J Interferon Res 1993; 13 (suppl 1): SI37.
15. de la Fuente J, Suva A, Ferez G, et al. Expresión del gen del interferon gamma humano en E. coli, in Proceedings of the II Cuban Seminar on Interferon-1 Cuban Seminar on Biotechnology, Part II. Instituto de Cooperación Iberoamericana, Madrid, La Habana, 1986, pp 740-751.
16. Munoz-Gomez J, Artritis reumatoidea, in Reumatologa Clmica, Rotés-Querol J eds, ESPAXS, Barcelona, 1983, pp 75-97.
17. Brewer EJ, Giannini EH, Kuzmina N, Alekseev L. Penicillamide and hydroxycholoquine in the treatment of severejuvenile rheumatoid arthritis: results of the USA-USSR double-blind placebo-controlled trial. N Eng J Med 1986; 314: 12691276.
18. Giannini EH, Brewer EJ, Kuzmina N, Alekseev, L Shokh BP. Characteristics of responders and nonresponders to slow acting anti-rheumatic drugs in juvenile rheumatoid arthritis. Arthritis Rheum 1988; 31: 15-20.
19. Giannini EH, Brewer EJ, Kuzmina N, Shaikov A, Wallin B. Auranofin in the treatment of juvenile rheumatoid arthritis: results ofthe USA-USSR double-blind placebo-controlled trial. Arthritis Rheum 1990; 33: 466-476.
20. Quesada JR. Toxicity and side effects of interferons, in Interferon. Principles and Medical Applications, Baron S, Coppenhaver DH, Dianzani F et al. eds. University of Texas Medical Branch, Galveston, 1992, pp. 427-432.
21. Feldmann M, Brennan FM, Maini RN. Role of cytokines in Rheumatoid arthritis. Ann Rev Immunol 1996; 14: 397-440.
22. Adams DO. Regulation of macrophage function by interferon gamma, in Interferon. Principles and Medical Applications, Baron S, Coppenhaver DH, Dianzani F et al. eds. University of Texas Medical Branch, Galveston, 1992, pp. 341-351.
23. Skoskiewicz MJ, Covin RB, Schneeberger EE, Russell PS. Widespread and selective induction of major histocompatibility complex-determined antigens in vivo by Gamma interferon. JExptlMed 1985; 162: 1645-1664.
24. Adams DH, Lloyd AR. Chemokines: leukocyte recruitment and activation cytokines. Lancet 1997; 349: 490-495.
25. Firestein GS, Alvaro-Gracia JM, Maki R. Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J Immunol 1990; 140: 3347-3352.
26. al-Janadi N; al-Dalaan A, al-Balla-S; Raziuddin S. CD4+ T cell inducible immunoregulatory cytokine response in rheumatoid arthritis. J Rheumatol 1996; 23(5): 809-814.
27. Verbruggen G, Malfait AM, Veys EM, Gyselbrecht L, Lambert J, Almqvist KF, Influence of interferon gamma on isolated chondrocytes from human articular cartilage. Dose dependent inhibition of cell proliferation and proteoglycan synthesis. J Rheumatol 1993; 20(6): 1020-1026.
28. Kahari VM, Heino J, Vuorio T, Vuorio E. Interferon alpha and interferon gamma reduce excessive collagen synthesis and procollagen mRNA levels of scleroderma fibroblasts in culture. Biochi Biophys Acta 1988; 968 (1): 45-50.
29. Firestein GS. Cytokines in autoimmune diseases, in Clinical and Molecular Aspects of Autoimmune Diseases. Concepts Immunopathol. Cruse JM, Lewis RE Jr eds, Karger, Basel, 1992, vol. 8, pp 129-160.